G. Bandara

发表

Functional evolution and structural conservation in chimeric cytochromes p450: calibrating a structure-guided approach.

Christopher A. Voigt, Jeffrey B. Endelman, C. Voigt, 2004, Chemistry & biology.

Activation Phenotype Stem Cell Factor Programs the Mast Cell

G. Bandara, D. Metcalfe, H. Kuehn, 2012 .

Stem Cell Factor Programs the Mast Cell Activation Phenotype

G. Bandara, D. Metcalfe, H. Kuehn, 2012, The Journal of Immunology.

The synovial activation of chondrocytes: evidence for complex cytokine interactions involving a possible novel factor.

G. Bandara, C. Evans, H. Georgescu, 1992, Biochimica et biophysica acta.

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer.

G. Bandara, P. Robbins, J. Glorioso, 1993, Proceedings of the National Academy of Sciences of the United States of America.

CD72 Negatively Regulates KIT-Mediated Responses in Human Mast Cells

G. Bandara, D. Metcalfe, A. Gilfillan, 2010, The Journal of Immunology.

Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production.

G. Bandara, V. Hox, D. Metcalfe, 2015, The Journal of allergy and clinical immunology.

Genotype-Dependent Effects of TGF-

G. Bandara, S. Spiegel, D. Conrad, 2013 .

Responses in Human Mast Cells CD72 Negatively Regulates KIT-Mediated

G. Bandara, D. Metcalfe, A. Gilfillan, 2010 .

Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype.

G. Bandara, E. Fischer, L. Scott, 2014, The Journal of allergy and clinical immunology.

IL-33 Induces a Hyporesponsive Phenotype in Human and Mouse Mast Cells

G. Bandara, Shoko Iwaki, D. Metcalfe, 2013, The Journal of Immunology.

Prevention of F‐actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells

G. Bandara, D. Metcalfe, A. Gilfillan, 2013, European journal of immunology.

Immunophenotypic and Ultrastructural Analysis of Mast Cells in Hermansky-Pudlak Syndrome Type-1: A Possible Connection to Pulmonary Fibrosis

G. Bandara, W. Gahl, K. Stone, 2016, PLoS ONE.

CRITICAL SIGNALING EVENTS IN THE MECHANOACTIVATION OF HUMAN MAST CELLS VIA P.C492Y-ADGRE2.

G. Bandara, D. Kastner, D. Metcalfe, 2020, The Journal of investigative dermatology.

Gene transfer to synoviocytes: prospects for gene treatment of arthritis.

G. Bandara, P. Robbins, J. Glorioso, 1992, DNA and cell biology.

Genotype-Dependent Effects of TGF-β1 on Mast Cell Function: Targeting the Stat5 Pathway

G. Bandara, S. Spiegel, D. Conrad, 2013, The Journal of Immunology.

Growth of human mast cells from bone marrow and peripheral blood-derived CD34(+) pluripotent hematopoietic cells.

G. Bandara, D. Metcalfe, A. Kirshenbaum, 2015, Methods in molecular biology.

Chondrocyte activation by interleukin-1: analysis of the synergistic properties of fibroblast growth factor and phorbol myristate acetate.

G. Bandara, C. Evans, H. Georgescu, 1989, Archives of biochemistry and biophysics.

Induction of collagenase mRNA in lapine articular chondrocytes by synovial factors and interleukin-1.

G. Bandara, C. Brinckerhoff, C. Evans, 1988, Archives of biochemistry and biophysics.

Critical Signaling Events in the Mechanoactivation of Human Mast Cells through p.C492Y-ADGRE2

G. Bandara, D. Kastner, D. Metcalfe, 2020 .

Functional expression of horseradish peroxidase in Saccharomyces cerevisiae and Pichia pastoris.

F. Arnold, G. Bandara, P. Cirino, 2000, Protein engineering.

Examination of the role of TRPM8 in human mast cell activation and its relevance to the etiology of cold-induced urticaria.

G. Bandara, D. Metcalfe, A. Gilfillan, 2011, Cell calcium.

Targeting the KIT Activating Switch Control Pocket: A Novel Mechanism to Inhibit Neoplastic Mast Cell Proliferation and Mast Cell Activation

G. Bandara, D. Metcalfe, O. Simakova, 2012, Leukemia.

Mastocytosis-derived extracellular vesicles deliver miR-23a and miR-30a into pre-osteoblasts and prevent osteoblastogenesis and bone formation

G. Bandara, Ho Min Kim, D. Metcalfe, 2021, Nature Communications.

Synovial activation of chondrocytes: Evidence for complex cytokine interactions

G. Bandara, C. Evans, H. Georgescu, 1991, Agents and Actions.

Regulation of Reactive Oxygen Species and the Antioxidant Protein DJ-1 in Mastocytosis

G. Bandara, D. Metcalfe, A. Olivera, 2016, PloS one.

Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production

G. Bandara, D. Metcalfe, A. Olivera, 2020, Haematologica.

Expression and stabilization of galactose oxidase in Escherichia coli by directed evolution.

F. Arnold, G. Bandara, F H Arnold, 2001, Protein engineering.

Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo.

G. Bandara, P. Robbins, C. Evans, 1996, Arthritis and rheumatism.

Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT

G. Bandara, D. Metcalfe, A. Olivera, 2018, Front. Immunol..

KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells.

G. Bandara, K. Dyer, L. Scott, 2013, Experimental hematology.

Chondrocyte activation by interleukin-1: Synergism with fibroblast growth factor and phorbol myristate acetate

G. Bandara, C. Evans, H. Georgescu, 1989, Agents and Actions.

Characterization and Comparison of Human LAD1 Mast Cells with Human LAD2 Mast Cells: 547

G. Bandara, D. Metcalfe, Yuzhi Yin, 2019, Journal of Allergy and Clinical Immunology.

Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation

G. Bandara, D. Metcalfe, A. Olivera, 2018, Proceedings of the National Academy of Sciences.

Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33

G. Bandara, D. Metcalfe, A. Olivera, 2015, European journal of immunology.

Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450.

F. Arnold, G. Bandara, Katsuyuki Takahashi, 2006, Biotechnology and bioengineering.

Synovial cell transplants for gene transfer to joints.

G. Bandara, P. Robbins, C. Evans, 1992, Transplantation proceedings.

CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis

G. Bandara, J. Lack, D. Metcalfe, 2023, Frontiers in Immunology.

A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.

G. Bandara, D. Metcalfe, B. Mock, 2013, Journal of immunological methods.

Description and Characterization of a Novel Human Mast Cell Line for Scientific Study

G. Bandara, Yuzhi Yin, J. B. Sundstrom, 2019, International journal of molecular sciences.

Functional contributions of the FcepsilonRIalpha and FepsilonRIgamma subunit domains in FcepsilonRI-mediated signaling in mast cells.

G. Bandara, A. Gilfillan, J. Kochan, 1996, Journal of immunology.

INTRAARTICULAR EXPRESSION OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN BY EXVIVO GENE-TRANSFER

G. Bandara, P. Robbins, J. Glorioso, 1993 .

Activation Phenotype Stem Cell Factor Programs the Mast Cell

G. Bandara, D. Metcalfe, H. Kuehn, 2012 .

Saturation mutagenesis.

G. Bandara, Lianhong Sun, Lianhong Sun, 2003, Methods in molecular biology.

CRITICAL SIGNALING EVENTS IN THE MECHANOACTIVATION OF HUMAN MAST CELLS VIA P.C492Y-ADGRE2

G. Bandara, Margery G. Smelkinson, Hirsh D. Komarow, 2020 .

This information is current as Activation Phenotype Stem Cell Factor Programs the Mast Cell Gilfillan

G. Bandara, D. Metcalfe, H. Kuehn, 2012 .

IL-33 Induces a Hyporesponsive Phenotype in Human and Mouse Mast Cells

G. Bandara, Shoko Iwaki, D. Metcalfe, 2013, The Journal of Immunology.

Activation of the receptor KIT induces the secretion of exosome‐like small extracellular vesicles

G. Bandara, Jennifer D. Petersen, Guido H. Falduto, 2024, Journal of extracellular biology.